# 1. Financial Performance ## A. Key Figures * **EBITDA:** **₹12.22 Cr** (+6.31%) · **8.55%** Margin * **PAT:** **₹552.26 Lakhs** Consolidated (+15.47%) · **₹3.73 Cr** to **₹7.37 Cr** Standalone range * **PAT Margin:** **3.87%** Consolidated ## B. Profitability & Cash Flow * **Earnings Momentum:** Consolidated bottom-line growth outpaced revenue expansion, though standalone profitability faced pressure, declining from **₹8 Cr to ₹6 Cr** in specific segments. * **Liquidity Divergence:** Management disputes claims of negative operational cash flow despite data suggesting a reduction in cash generation at the standalone level. ## C. Working Capital Trends * **Strategic Inventory Buffering:** Capital raised was deployed to bolster stock levels as a hedge against **global material scarcity**, ensuring supply chain continuity. * **Balance Sheet Reallocation:** Management utilized funds to aggressively reduce creditor obligations while simultaneously managing an increase in debtor outstandings. --- # 2. Capital Allocation & Funding ## A. Key Figures * **Total Project CAPEX:** **₹120 Cr** CBG Project · **~₹120 Cr** BioFuels/Pellets · **₹30 Cr** Atrazine Capacity * **Funding Sources (CBG):** **₹85 Cr** Finalized Debt · **₹36 Cr** Warrant Equity * **Warrant Progress:** **₹16-17 Cr** Raised in FY26 · **₹33 Cr** Total Collection Target * **IPO Utilization:** **₹40 Cr** Total Raised · **₹30 Cr** Allocated to Working Capital (75%) ## B. CAPEX Investment Plan * **Strategic Diversification:** Significant capital deployment into Atrazine manufacturing and BioFuels to enhance market positioning and product mix. * **Operational Optimization:** CAPEX and inventory investments are specifically targeted at resolving historical **under-utilization of production capacities** and stock-outs. * **Execution Timeline:** Management committed to a **1-1.5 year** expansion phase while maintaining a conservative financial profile. ## C. Debt & Equity Mix * **Lab Expansion Funding:** Minimal leverage strategy for lab facilities, utilizing **₹8-10 Cr** in nominal debt with the balance met via internal accruals. * **Warrant Utilization:** Equity portion of major projects is being serviced through phased warrant drawdowns to support capital-intensive ventures. ## D. Project Financial Closure * **CBG Funding Secured:** Financial closure achieved for the initial Compressed Bio-Gas investment, supported by a **₹80 Cr** bank loan sanction. * **Sequential BioFuel Funding:** Financial closure for the BioFuel/Pellets segment is scheduled to follow the commencement of CBG construction. --- # 3. Capacity & Production ## A. Key Figures * **Capacity Utilization:** **71%** current (Expected range **70%–75%**) * **Agrochemical CAPEX:** **₹30 Cr** Brownfield expansion * **CBG Project Cost:** **>₹120 Cr** Estimated * **CBG Production Capacity:** **15 TPD** Nameplate · **18 TPD** Expected actual output ## B. Agrochemical Lab Expansion * **Strategic Scaling:** Significant brownfield expansion underway at the existing **5-acre** facility to strengthen manufacturing and broaden the product portfolio. * **Expansion Driver:** Current utilization levels have triggered the need for fresh CAPEX to sustain growth over the coming years. ## C. CBG Plant Development * **Project Timeline:** Development of the Dhansa Green Energy project near Kota is slated for commercial operations by **July 2027**. * **Infrastructure Footprint:** Project encompasses **17 acres** for the primary plant and **5 acres** for a BioFuel facility within the Bundi district. ## D. Utilization & Feedstock * **Integrated Ecosystem:** Establishing one of India’s largest integrated feedstock operations, utilizing **350 acres** of leased land for Napier grass cultivation. * **Resource Security:** The dedicated cultivation project creates a sustainable feedstock ecosystem to support high-output renewable energy operations. --- # 4. Product & Segment Performance ## A. Key Figures * **Atrazine Project Revenue:** **₹120–140 Cr** projected annual contribution at stabilization * **Atrazine Capital Expenditure:** **₹30 Cr** estimated investment * **Customer Base:** **290+** existing agrochemical clients for biofertilizer distribution ## B. Atrazine Project Contribution * **High-Yield Expansion:** The new project is set to deliver significant top-line growth relative to a modest capital outlay, signaling high asset turnover potential. ## C. Renewable Energy & Biofuels * **Strategic Diversification:** Operations are being scaled through dedicated subsidiaries (Dhansa Green Energy and Dhansa Biofuels) to capture tailwinds from sustainable energy policies. * **Industrial Decarbonization:** Focus on biomass pellets as a coal alternative serves as a primary pillar for long-term non-chemical revenue streams. * **Circular Economy Integration:** The **Compressed Biogas (CBG)** project creates a dual-revenue stream by converting byproducts into biofertilizers for the existing lab customer base. ## D. Carbon Credit Generation * **Monetizing Sustainability:** The Rajasthan project utilizes Napier grass to build a carbon credit portfolio, offering both direct value generation and environmental offsetting. * **Regulatory Compliance:** Credits will be leveraged internally to nullify the environmental footprint of the company’s labs, ensuring balance for large-scale corporate operations. --- # 5. Strategy & Market Mix ## A. Strategic Market Expansion * **Global Footprint:** Management is aggressively targeting high-potential export markets, specifically **Australia, Latin America, and the United States**, to diversify revenue streams despite global trade volatility. * **Logistical Efficiency:** The Napier Grass project leverages a strategic location along the **Delhi-Mumbai Expressway**, providing a significant competitive advantage in connectivity to major industrial hubs. ## B. Operational Sustainability & Security * **Feedstock De-risking:** The transition to Napier grass as a primary feedstock ensures long-term raw material security and price stability for the next **10 to 20 years**, insulating the business from the volatility of agro-waste markets. * **Resource Availability:** Extensive research identifies significant land scalability in the **Bundi area of Rajasthan**, with an estimated **3,500 to 4,000 acres** available for feedstock cultivation. * **Revenue Visibility:** The Compressed Biogas (CBG) segment is de-risked via long-term off-take agreements, featuring committed sales contracts with large corporates spanning the next **8 to 10 years**. --- # 6. Risks & Agrochemical Factors ## A. Global Pricing Volatility * **Pricing Recovery:** Stagnant sales growth resulted from a global contraction in finished goods pricing, though management observes a recent **reversal in price trends**. ## B. Subsidiary Gestation Losses * **Strategic Expansion Risks:** The company is funding the launch of two new subsidiaries, including a biofuels venture, despite the core business currently generating **negative cash flow**. * **Subsidiary Drag:** Initial financial results from Dhansa Green Energy reflect early-stage gestation losses and a lack of commercial contribution to the top line. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth Target:** **~20%** Current Year * **Atrazine Project Contribution:** **₹40 Cr** Initial Year Revenue * **Trade Receivables Increase:** **₹13 Cr** Impact from export delays ## B. Revenue & Project Timelines * **Growth Outlook:** Management anticipates robust double-digit top-line expansion for the current year, though **FY27** visibility remains limited pending the completion of ongoing CAPEX. * **Atrazine Commissioning:** Project launch is slated for **August**, with full stabilization expected by year-end to drive incremental revenue. ## C. Working Capital & Strategic Priorities * **Receivables Normalization:** Elevated trade receivables are expected to revert to historical levels by **H1**, as global logistics and port disruptions stabilize. * **Capacity Expansion:** Strategic focus for the next **2-3 years** centers on aggressive scaling across primary labs and subsidiaries to support long-term clean energy ambitions.